$KYMR
Kymera Therapeutics, Inc. Stock $kymr

$kymr Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000095017022006947 Filed on May 03, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$9.622M	$18.70M
YoY Change	-48.55%	445.57%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$10.61M	$5.910M
YoY Change	79.54%
% of Gross Profit
Research & Development	$35.94M	$25.96M
YoY Change	38.45%	114.28%
% of Gross Profit
Depreciation & Amortization	$687.0K	$485.0K
YoY Change	41.65%	25.32%
% of Gross Profit
Operating Expenses	$46.56M	$31.87M
YoY Change	46.07%	117.18%
Operating Profit	-$36.93M	-$13.17M
YoY Change	180.45%	17.09%
Interest Expense	$249.0K	$90.00K
YoY Change	176.67%
% of Operating Profit
Other Income/Expense, Net	$249.0K	$94.00K
YoY Change	164.89%	-70.16%
Pretax Income	-$36.68M	-$13.08M
YoY Change	180.46%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$36.68M	-$13.08M
YoY Change	180.57%	19.6%
Net Earnings / Revenue	-381.25%	-69.91%
Basic Earnings Per Share	-$0.71
Diluted Earnings Per Share	-$710.2K	-$292.9K
COMMON SHARES
Basic Shares Outstanding	51.70M	44.81M
Diluted Shares Outstanding	51.65M

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$420.8M	$333.5M
YoY Change	26.18%
Cash & Equivalents	$33.73M	$53.10M
Short-Term Investments	$387.1M	$280.4M
Other Short-Term Assets	$9.307M	$5.500M
YoY Change	69.22%
Inventory
Prepaid Expenses
Receivables	$1.263M	$900.0K
Other Receivables	$0.00	$800.0K
Total Short-Term Assets	$431.4M	$340.8M
YoY Change	26.58%
LONG-TERM ASSETS
Property, Plant & Equipment	$11.76M	$20.50M
YoY Change	-42.64%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$102.5M	$101.6M
YoY Change	0.86%
Other Assets	$2.022M	$1.600M
YoY Change	26.38%
Total Long-Term Assets	$131.7M	$123.8M
YoY Change	6.36%
TOTAL ASSETS
Total Short-Term Assets	$431.4M	$340.8M
Total Long-Term Assets	$131.7M	$123.8M
Total Assets	$563.1M	$464.6M
YoY Change	21.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.567M	$8.300M
YoY Change	-69.07%
Accrued Expenses	$20.78M	$13.00M
YoY Change	59.82%
Deferred Revenue	$60.85M
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.087M	$600.0K
YoY Change	81.17%
Total Short-Term Liabilities	$88.34M	$110.1M
YoY Change	-19.79%
LONG-TERM LIABILITIES
Long-Term Debt	$927.0K	$500.0K
YoY Change	85.4%
Other Long-Term Liabilities	$273.0K	$92.00K
YoY Change	196.74%
Total Long-Term Liabilities	$273.0K	$92.00K
YoY Change	196.74%
TOTAL LIABILITIES
Total Short-Term Liabilities	$88.34M	$110.1M
Total Long-Term Liabilities	$273.0K	$92.00K
Total Liabilities	$134.3M	$189.3M
YoY Change	-29.04%
SHAREHOLDERS EQUITY
Retained Earnings	-$265.7M	-$141.8M
YoY Change	87.32%
Common Stock	$697.6M	$417.1M
YoY Change	67.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$428.7M	$275.2M
YoY Change
Total Liabilities & Shareholders Equity	$563.1M	$464.6M
YoY Change	21.2%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	-$36.68M	-$13.08M
YoY Change	180.57%	19.6%
Depreciation, Depletion And Amortization	$687.0K	$485.0K
YoY Change	41.65%	25.32%
Cash From Operating Activities	-$40.30M	-$22.82M
YoY Change	76.55%	89.29%
INVESTING ACTIVITIES
Capital Expenditures	$482.0K	$164.0K
YoY Change	193.9%	-88.24%
Acquisitions
YoY Change
Other Investing Activities	$26.35M	$44.50M
YoY Change	-40.8%
Cash From Investing Activities	$25.86M	$44.32M
YoY Change	-41.65%	-218.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	185.0K	595.0K
YoY Change	-68.91%	-99.36%
NET CHANGE
Cash From Operating Activities	-40.30M	-22.82M
Cash From Investing Activities	25.86M	44.32M
Cash From Financing Activities	185.0K	595.0K
Net Change In Cash	-14.25M	22.10M
YoY Change	-164.48%	-49.39%
FREE CASH FLOW
Cash From Operating Activities	-$40.30M	-$22.82M
Capital Expenditures	$482.0K	$164.0K
Free Cash Flow	-$40.78M	-$22.99M
YoY Change	77.39%	70.88%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022Q1	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	us-gaap	Change In Accounting Principle Accounting Standards Update Adopted ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted	true
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001815442
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q1	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#RevenueFromRelatedParties
CY2022Q1	kymr	Net Operating Loss Carryforwards Period Cares Act NetOperatingLossCarryforwardsPeriodCARESAct	P5Y
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02472
CY2022Q1	dei	City Area Code CityAreaCode	857
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	285-5300
CY2022Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2022Q1	us-gaap	Change In Accounting Principle Accounting Standards Update Immaterial Effect ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect	true
CY2022Q1	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#RevenueFromRelatedParties
CY2022Q1	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-39460
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	KYMERA THERAPEUTICS, INC.
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	81-2992166
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	200 Arsenal Yards Blvd
CY2022Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 230
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Watertown
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2022Q1	dei	Trading Symbol TradingSymbol	KYMR
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	51724179
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33733000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	47976000
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	387079000
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	394442000
CY2022Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1263000
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	135000
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9307000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8720000
CY2022Q1	us-gaap	Assets Current AssetsCurrent	431382000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	451273000
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	102478000
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	125187000
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11759000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11881000
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9307000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9426000
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2022000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2022000
CY2022Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	6112000
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	6116000
CY2022Q1	us-gaap	Assets Assets	563060000
CY2021Q4	us-gaap	Assets Assets	605905000
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2567000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4005000
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	20777000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	22971000
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	60852000
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	61739000
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2480000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2461000
CY2022Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1087000
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1138000
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	576000
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	228000
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	88339000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	92542000
CY2022Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	31823000
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	39295000
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	12978000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	13224000
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	927000
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1140000
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	273000
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	66000
CY2022Q1	us-gaap	Liabilities Liabilities	134340000
CY2021Q4	us-gaap	Liabilities Liabilities	146267000
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	51716194
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	51573924
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	51692666
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	51536181
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	5000
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	5000
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	697597000
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	689275000
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-265666000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-228982000
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3216000
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-660000
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	428720000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	459638000
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	563060000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	605905000
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9622000
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	18702000
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	35944000
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	25962000
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10611000
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5909000
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	46555000
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	31871000
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-36933000
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-13169000
CY2022Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	290000
CY2021Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	118000
CY2022Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	41000
CY2021Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	24000
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	249000
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	94000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-36684000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-13075000
CY2022Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-2556000
CY2021Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	115000
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-39240000
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12960000
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-36684000
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13075000
CY2022Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.71
CY2021Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.29
CY2022Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	51651125
CY2021Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	44649572
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	283888000
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1147000
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3172000
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	115000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-13075000
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	275247000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	459638000
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	449000
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7873000
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-2556000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-36684000
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	428720000
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-36684000
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-13075000
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	7873000
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3172000
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	687000
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	485000
CY2022Q1	kymr	Premiums And Discounts On Available For Sale Marketable Securities PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities	1175000
CY2021Q1	kymr	Premiums And Discounts On Available For Sale Marketable Securities PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities	1279000
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	586000
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	816000
CY2021Q1	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	279000
CY2022Q1	kymr	Increase Decrease In Contract With Customer Asset Related Parties IncreaseDecreaseInContractWithCustomerAssetRelatedParties	1128000
CY2021Q1	kymr	Increase Decrease In Contract With Customer Asset Related Parties IncreaseDecreaseInContractWithCustomerAssetRelatedParties	22000
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1437000
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4150000
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2278000
CY2021Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	235000
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-8359000
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-17822000
CY2022Q1	kymr	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	-119000
CY2021Q1	kymr	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	-95000
CY2022Q1	kymr	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-227000
CY2021Q1	kymr	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-368000
CY2022Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-550000
CY2021Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-143000
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-40295000
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-22823000
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	482000
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	164000
CY2022Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	80118000
CY2021Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	16013000
CY2022Q1	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	106463000
CY2021Q1	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	60500000
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	25863000
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	44323000
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	449000
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1147000
CY2021Q1	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering	397000
CY2022Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	264000
CY2021Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	155000
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	185000
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	595000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-14247000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	22095000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	54092000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	32593000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	39845000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	54688000
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	46000
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	24000
CY2022Q1	kymr	Property And Equipment Purchases Included In Accounts Payable And Accrued Expenses PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses	126000
CY2021Q1	kymr	Property And Equipment Purchases Included In Accounts Payable And Accrued Expenses PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses	259000
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33733000
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	53098000
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	6112000
CY2021Q1	us-gaap	Restricted Cash RestrictedCash	1590000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	39845000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	54688000
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-265700000
CY2022Q1	us-gaap	Investments And Cash InvestmentsAndCash	523300000
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	467000000.0
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	113
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	515400000
CY2021Q4	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0
CY2022Q1	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0
CY2022Q1	us-gaap	Fair Value Assets Level2 To Level1 Transfers Amount FairValueAssetsLevel2ToLevel1TransfersAmount	0
CY2021Q4	us-gaap	Fair Value Assets Level2 To Level1 Transfers Amount FairValueAssetsLevel2ToLevel1TransfersAmount	0
CY2022Q1	kymr	Fair Value Assets Level1 To Level3 Transfers Amount FairValueAssetsLevel1ToLevel3TransfersAmount	0
CY2021Q4	kymr	Fair Value Assets Level1 To Level3 Transfers Amount FairValueAssetsLevel1ToLevel3TransfersAmount	0
CY2022Q1	kymr	Fair Value Assets Level3 To Level1 Transfers Amount FairValueAssetsLevel3ToLevel1TransfersAmount	0
CY2021Q4	kymr	Fair Value Assets Level3 To Level1 Transfers Amount FairValueAssetsLevel3ToLevel1TransfersAmount	0
CY2022Q1	kymr	Fair Value Assets Level3 To Level2 Transfers Amount FairValueAssetsLevel3ToLevel2TransfersAmount	0
CY2021Q4	kymr	Fair Value Assets Level3 To Level2 Transfers Amount FairValueAssetsLevel3ToLevel2TransfersAmount	0
CY2022Q1	kymr	Fair Value Assets Level2 To Level3 Transfers Amount FairValueAssetsLevel2ToLevel3TransfersAmount	0
CY2021Q4	kymr	Fair Value Assets Level2 To Level3 Transfers Amount FairValueAssetsLevel2ToLevel3TransfersAmount	0
CY2022Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	492767000
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	6000
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	3216000
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	489557000
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	520286000
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1000
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	658000
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	519629000
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	121
CY2022Q1	kymr	Debt Securities Available For Sale Contractual Maturity Of Less Than12 Months Number Of Securities DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities	86
CY2022Q1	kymr	Fair Value Of Available For Sale Debt Securities Contractual Maturity Of Less Than Twelve Months FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths	387100000
CY2022Q1	kymr	Debt Securities Available For Sale Contractual Maturity Of12 Months Or Longer Number Of Securities DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities	38
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	102500000
CY2021	kymr	Debt Securities Available For Sale Contractual Maturity Of Less Than12 Months Number Of Securities DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities	79
CY2021Q4	kymr	Fair Value Of Available For Sale Debt Securities Contractual Maturity Of Less Than Twelve Months FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths	394400000
CY2021	kymr	Debt Securities Available For Sale Contractual Maturity Of12 Months Or Longer Number Of Securities DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities	37
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	125200000
CY2022Q1	us-gaap	Availableforsale Securities Sold At Par AvailableforsaleSecuritiesSoldAtPar	0
CY2021Q1	us-gaap	Availableforsale Securities Sold At Par AvailableforsaleSecuritiesSoldAtPar	0
CY2022Q1	kymr	Available For Sale Securities Credit Losses AvailableForSaleSecuritiesCreditLosses	0
CY2021Q4	kymr	Available For Sale Securities Credit Losses AvailableForSaleSecuritiesCreditLosses	0
CY2022Q1	kymr	Collaboration Termination Date CollaborationTerminationDate	2022-04-27
CY2021Q4	us-gaap	Contract With Customer Receivable After Allowance For Credit Loss ContractWithCustomerReceivableAfterAllowanceForCreditLoss	135000
CY2022Q1	kymr	Contract With Customer Asset Net Additions ContractWithCustomerAssetNetAdditions	1398000
CY2022Q1	kymr	Contract With Customer Asset Net Deductions ContractWithCustomerAssetNetDeductions	270000
CY2022Q1	us-gaap	Contract With Customer Receivable After Allowance For Credit Loss ContractWithCustomerReceivableAfterAllowanceForCreditLoss	1263000
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	101034000
CY2022Q1	kymr	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	1263000
CY2022Q1	kymr	Contract With Customer Liability Deductions ContractWithCustomerLiabilityDeductions	-9622000
CY2022Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	92675000
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	16361000
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	15797000
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4602000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3916000
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11759000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11881000
CY2022Q1	us-gaap	Depreciation Depreciation	700000
CY2021Q1	us-gaap	Depreciation Depreciation	500000
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	300000
CY2021Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	200000
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	524000
CY2021Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	524000
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	279000
CY2021Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	178000
CY2022Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	46000
CY2021Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	24000
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	329000
CY2021Q1	us-gaap	Variable Lease Cost VariableLeaseCost	232000
CY2022Q1	us-gaap	Lease Cost LeaseCost	1178000
CY2021Q1	us-gaap	Lease Cost LeaseCost	958000
CY2022Q1	kymr	Operating Lease Payments Proceeds OperatingLeasePaymentsProceeds	631000
CY2021Q1	kymr	Operating Lease Payments Proceeds OperatingLeasePaymentsProceeds	797000
CY2022Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	264000
CY2021Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	155000
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	46000
CY2021Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	24000
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y1M2D
CY2021Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y1M2D
CY2022Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y1M6D
CY2021Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y7M6D
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1050
CY2021Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1050
CY2022Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0875
CY2021Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0812
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1950000
CY2022Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	874000
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2659000
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	969000
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2732000
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	343000
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2814000
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	0
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2898000
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	0
CY2022Q1	kymr	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	10027000
CY2022Q1	kymr	Finance Lease Liability Payments Due After Year Four FinanceLeaseLiabilityPaymentsDueAfterYearFour	0
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	23080000
CY2022Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	2186000
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	7622000
CY2022Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	172000
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	15458000
CY2022Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	2014000
CY2021Q4	kymr	Accrued Research And Development Expenses Current AccruedResearchAndDevelopmentExpensesCurrent	15169000
CY2022Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	2287000
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	6033000
CY2022Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1977000
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1417000
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	344000
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	352000
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	20777000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	22971000
CY2022Q1	kymr	Accrued Research And Development Expenses Current AccruedResearchAndDevelopmentExpensesCurrent	16169000
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y9M21D
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y9M21D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.62
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.66
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0159
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0084
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7873000
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3172000
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2022Q1	kymr	Net Operating Loss Carryforwards Percentage Limitations On Use Cares Act NetOperatingLossCarryforwardsPercentageLimitationsOnUseCARESAct	0.80
CY2022Q1	kymr	Expected Income Tax Refund Period Cares Act ExpectedIncomeTaxRefundPeriodCARESAct	P18M
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-36684000
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13075000
CY2022Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	51651125
CY2021Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	44649572
CY2022Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.71
CY2021Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.29
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7241028
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6914143

Files In Submission

Name	View Source	Status
0000950170-22-006947-index-headers.html	Edgar Link	pending
0000950170-22-006947-index.html	Edgar Link	pending
0000950170-22-006947.txt	Edgar Link	pending
0000950170-22-006947-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
kymr-20220331.htm	Edgar Link	pending
kymr-20220331.xsd	Edgar Link	pending
kymr-20220331_cal.xml	Edgar Link	unprocessable
kymr-20220331_def.xml	Edgar Link	unprocessable
kymr-20220331_htm.xml	Edgar Link	completed
kymr-20220331_lab.xml	Edgar Link	unprocessable
kymr-20220331_pre.xml	Edgar Link	unprocessable
kymr-ex31_1.htm	Edgar Link	pending
kymr-ex31_2.htm	Edgar Link	pending
kymr-ex32_1.htm	Edgar Link	pending
kymr-ex32_2.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KYMR
Kymera Therapeutics, Inc. Stock $kymr

2022 Q1 Form 10-Q Financial Statement

#000095017022006947 Filed on May 03, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KYMR Kymera Therapeutics, Inc. Stock $kymr

2022 Q1 Form 10-Q Financial Statement

#000095017022006947 Filed on May 03, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KYMR
Kymera Therapeutics, Inc. Stock $kymr